CYSTIC FIBROSIS -RELATED BONE DISEASE

  • Kátia Cardoso S. de Pediatria Médica, CH Lisboa Norte, Hospital de Santa Maria
  • Luía Pereira Centro Especializado de Fibrose Quística, CH Lisboa Norte, H Santa Maria; Clínica Universitária de Pediatria, Faculdade de Medicina, Universidade de Lisboa
  • Celeste Barreto Centro Especializado de Fibrose Quística, CH Lisboa Norte, H Santa Maria; Clínica Universitária de Pediatria, Faculdade de Medicina, Universidade de Lisboa
Keywords: Children, cystic fibrosis related bone disease

Abstract

Introduction: More than seven decades have passed since the first description of cystic fibrosis as a deadly childhood disease. Since then, progress has been made to extend the lives of these patients. As a consequence, children with cystic fibrosis are living into adulthood, which was once an unexpected outcome. Nevertheless, this increased survival brought new secondary complications as well as problems caused by the long -lasting medication. Cystic fibrosis -related bone disease is a recent but common complication in long -term survivors. Since its first description in 1979, a large number of papers have been published concerning the various areas of research around this secondary complication of cystic fibrosis.

Aims: This article attempts to review the literature related to several research areas around the cystic fibrosis -related bone disease summarizing the most relevant aspects of this problem.

Development: Throughout the article the authors emphasize knowledge about the epidemiology, pathophysiology and clinical aspects, and describe the most current recommendations for the diagnosis, prevention, treatment and monitoring of cystic fibrosis -related bone disease.

Conclusions: Multifactorial aetiology and interdependence and complexity of underlying pathological mechanisms stress the need and importance of monitoring patients with cystic fibrosis- -related bone disease in specialized centers that allow a multi- -and interdisciplinary integrated and differentiated follow -up.

References

Barreto C. Fibrose quística. In: Sociedade Portuguesa de

Pneumologia, eds. Tratado de Pneumologia. 1ª ed. Lisboa:

Permanyer Portugal; 2003. p. 927 -43.

Southern KW, Munck A, Pollitt R, Travert G, Zanolla L,

Dankert -Roelse J, et al. A survey of newborn screening

for cystic fibrosis in Europe. J Cyst Fibros 2007; 6:57 -65.

doi:10.1016/j.jcf.2006.05.008

Farrell P. The prevalence of cystic fibrosis in the European

Union. J Cyst Fibros 2008; 7:450 -3. doi:10.1016/j.

jcf.2008.03.007

Cystic Fibrosis Foundation: Patient Registry 2006 Annual

Report [Internet]. [citado 2012 Jun 15]. Disponível em:

http://www.cff.org/UploadedFiles/research/ClinicalResearch/

%20Patient%20Registry%20Report.pdf

Cystic Fibrosis Foundation: Cystic Fibrosis Foundation 2010

Annual Report [Internet]. [citado 2012 Jun 15]. Disponível

em: http://www.cff.org/UploadedFiles/aboutCFFoundation/

AnnualReport/2010 -Annual -Report.pdf

Mischler EH, Chesney PJ, Chesney RW, Mazess RB. Demineralization

in cystic fibrosis detected by direct photon absorptiometry.

Am J Dis Child 1979; 133:632 -5.

Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced

serum 25 -hydroxyvitamin D concentration and disordered

mineral metabolism in patients with cystic fibrosis. J Pediatr

; 94:38 -42. doi:10.1016/S0022 -3476(79)80346 -7

Elkin S. Arthritis, vasculitis and bone disease. In: Bush A, Alton

EWFW, Davies JC, Griesenbach U, Jaffe A, eds. Cystic

Fibrosis in the 21st Century. Progress in Respiratory Research.

Basel: Karger; 2006. Vol. 34. p. 270 -7.

Javier RM, Jacquot J. Bone disease in cystic fibrosis: What’s

new? Joint Bone Spine 2011; 78:445 -50. doi:10.1016/j.jbspin.

11.015

Sermet -Gaudelus I, Castanet M, Retsch -Bogart G, Aris RM.

Update on cystic fibrosis -related bone disease: a special

focus on children. Paediatr Respir Rev 2009; 10:134 -42.

doi:10.1016/j.prrv.2009.05.001

Sermet -Gaudelus I, Bianchi ML, Garabédian M, Aris RM,

Morton A, Hardin DS, et al. European cystic fibrosis bone

mineralisation guidelines. J Cyst Fibros 2011; 10:S16 -23.

doi:10.1016/S1569 -1993(11)60004 -0

Cystic Fibrosis Trust: Bone mineralisation in cystic fibrosis

[Internet]. [citado 2012 Jun 15]. Disponível em: http://www.

cftrust.org.uk/aboutcf/publications/consensusdoc/Bone-

-Mineral -Booklet.pdf

Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle

MP, Elkin SL, et al. Guide to bone health and disease in

cystic fibrosis. J Clin Endocrinol Metab 2005; 90:1888 -96.

doi:10.1210/jc.2004 -1629

Land C, Schoenau E. Fetal and postnatal bone development:

reviewing the role of mechanical stimuli and nutrition.

Best Pract Res Clin Endocrinol Metab 2008; 22:107 -18.

doi:10.1016/j.beem.2007.09.005

World Health Organization: Assessment of fracture risk and

its application to screening for postmenopausal osteoporosis:

report of WHO study group. [Internet]. [citado 2012 Jun 15].

Acessível em:http://whqlibdoc.who.int/trs/WHO_TRS_843.pdf

Reix P, Bellon G, Braillon P. Bone mineral and body composition

alterations in paediatric cystic fibrosis patients. Pediatr

Radiol 2010; 40:301 -8. doi:10.1007/s00247 -009 -1446 -8

Legroux -Gérot I, Leroy S, Prudhomme C, Perez T, Flipo

RM, Wallaert B, et al. Bone loss in adults with cystic fibrosis:

prevalence, associated factors, and usefulness of biological

markers. Joint Bone Spine 2012; 79:73 -7. doi:10.1016/j.jbspin.

05.009

Paccou J, Zeboulon N, Combescure C, Gossec L, Cortet

B. The prevalence of osteoporosis, osteopenia and fractures

among adults with cystic fibrosis: a systematic literature

review with meta -analysis. Calcif Tissue Int 2010; 86:1 -7.

doi:10.1007/s00223 -009 -9316 -9

Sermet -Gaudelus I, Souberbielle JC, Ruiz JC, Vrielynck S,

Heuillon B, Azhar I, et al. Low bone mineral density in young

children with cystic fibrosis. Am J Respir Crit Car Med 2007;

:951 -7. doi:10.1164/rccm.200606 -776OC

Caldeira RJ, Fonseca VM, Gomes Junior SC, Chaves CR.

Prevalence of bone mineral disease among adolescents with

cystic fibrosis. J Pediatr (Rio J) 2008; 84:18 -25. doi:10.2223/

JPED.1737

Gronowitz E, Garemo M, Lindblad A, Mellstrom D, Strandvik

B. Decreased bone mineral density in normal -growing

patients with cystic fibrosis. Acta Paediatr 2003; 92:688 -93.

doi:10.1111/j.1651 -2227.2003.tb00601.x

Ujhelyi R, Treszl A, Vasarhelyi B,Holics K, Tóth M, Arató

A, et al. Bone mineral density acquisition in children and

young adults with cystic fibrosis: a follow -up study. J Ped

Gastroenterol Nutr 2004; 38:401 -6. doi:10.1097/00005176-

-200404000 -00007

Bianchi ML, Romano G, Saraifoger S, Costantini D, Limonta

C, Colombo C. BMD and body composition in children and

young patients affected by cystic fibrosis. J Bone Miner Res

; 21:388 -96. doi:10.1359/JBMR.051106

Conway SP, Oldroyd B, Brownlee KG, Wolfe SP, Truscott

JG. A cross -sectional study of bone mineral density in children

and adolescents attending a Cystic Fibrosis Centre. J

Cyst Fibros 2008; 7:469 -76. doi:10.1016/j.jcf.2008.04.004

Grey V, Atkinson S, Drury D, Casey L, Ferland G, Gundberg

C, et al. Prevalence of low bone mass and deficiencies of

vitamins D and K in pediatric patients with cystic fibrosis

from 3 canadian centers. Pediatrics 2008; 122:1014 -20. doi:

1542/peds.2007 -2336

Laursen EM, Molgaard C, Michaelsen KF, Koch C, Muller J.

Bone mineral status in 134 patients with cystic fibrosis. Arch

Dis Child 1999; 81:235 -40. doi: 10.1136/adc.81.3.235

Mortensen LA, Chan GM, Alder SC, Marshall BC. Bone mineral

status in prepubertal children with cystic fibrosis. J Pediatr

; 136:648 -52. doi:10.1067/mpd.2000.104271

Sood M, Hambleton G, Super M, Fraser WD, Adams JE, Mughal

MZ. Bone status in cystic fibrosis. Arch Dis Child 2001;

:516 -20. doi:10.1136/adc.84.6.516

Hardin DS, Arumugam R, Seilheimer DK, LeBlanc A, Ellis KJ.

Normal bone mineral density in cystic fibrosis. Arch Dis Child

; 84:363 -8. doi:10.1136/adc.84.4.363

Buntain HM, Greer RM, Schluter PJ, Wong JC, Batch JA,

Potter JM, et al. Bone mineral density in australian children,

adolescents and adults with cystic fibrosis: a controlled cross

sectional study. Thorax 2004; 59:149 -55. doi:10.1136/thorax.

006726

Kelly A, Schall JI, Stallings VA, Zemel BS. Deficits in bone mineral

contents in children and adolescents with cystic fibrosis

are related to height deficits. J Clin Densitom 2008; 11:581 -9.

doi:10.1016/j.jocd.2008.07.002

Papaioannou A, Kennedy CC, Freitag A, O’Neill J, Pui M,

Ioannidis G, et al. Longitudinal analysis of vertebral fracture

and BMD in a Canadian cohort of adult cystic fibrosis patients.

BMC Musculoskelet Disord 2008; 9:125. doi:10.1186/1471-

-2474 -9 -125

Rovner AJ, Zemel BS, Leonard MB, Schall JI, Stallings VA.

Mild to moderate cystic fibrosis is not associated with increased

fracture risk in children and adolescents. J Pediatr 2005;

:327 -31. doi:10.1016/j.jpeds.2005.04.015

Buntain HM, Schluter PJ, Bell SC, Greer RM, Wong JC, Batch

J, et al. Controlled longitudinal study of bone mass accrual

in children and adolescents with cystic fibrosis. Thorax

; 61:146 -54. doi:10.1136/thx.2005.046516

Jacquot J, Tabary O, Clement A. Hyperinflammation in airways

of cystic fibrosis patients: what’s new? Expert Rev Mol

Diagn 2008; 8:359 -63. doi:10.1586/14737159.8.4.359

Haworth CS, Selby PL, Webb AK, Martin L, Elborn JS, Sharples

LD, et al. Inflammatory related changes in bone mineral

content in adults with cystic fibrosis. Thorax 2004; 59:613 -7.

doi:10.1136/thx.2003.012047

Shead EF, Haworth CS, Barker H, Bilton D, Compston JE.

Osteoclast function, bone turnover and inflammatory cytokines

during infective exacerbations of cystic fibrosis. J Cyst

Fibros 2010; 9:93 -8. doi:10.1016/j.jcf.2009.11.007

Ionescu AA, Evans WD, Pettit RJ, Nixon LS, Stone MD, Shale

DJ. Hidden depletion of fat -free mass and bone mineral

density in adults with cystic fibrosis. Chest 2003; 124:2220 -8.

doi:10.1378/chest.124.6.2220

Kawai M, Rosen CJ. Insulin -like growth factor -I and bone: lessons

from mice and men. Pediatr Nephrol. 2009; 24:1277 -85.

doi:10.1007/s00467 -008 -1040 -6

Hillman LS, Cassidy JT, Popescu MF, Hewett JE, Kyger J,

Robertson JD. Percent true calcium absorption, mineral metabolism,

and bone mineralization in children with cystic fibrosis:

effect of supplementation with vitamin D and calcium.

Pediatr Pulmonol 2008; 43:772 -80. doi:10.1002/art.23809

Schulze KJ, O’Brien KO, Germain -Lee EL, Baer D, Leonard

ALR, Rosenstein BR. Endogenous fecal losses of calcium

compromise calcium balance in pancreatic -insufficient girls

with cystic fibrosis. J Pediatr 2003; 143:765 -71. doi:10.1067/

S0022 -3476(03)00539 -0

Schulze KJ, Cutchins C, Rosenstein BJ,Germain -Lee EL,

O’BrienKO. Calcium acquisition rates do not support age-

-appropriate gains in total body mineral content in prepuberty

and late puberty in girls with cystic fibrosis. Osteoporos Int

; 17:731 -40. doi:10.1007/s00198 -005 -0041 -6

Borowitz D, Baker RD, Stallings V. Consensus report on

nutrition for pediatric patients with cystic fibrosis. J Pediatr

Gastroenterol Nutr 2002; 35:246 -59. doi:10.1097/01.

MPG.0000025580.85615.14

Hall WB, Sparks AA, Aris RM. Vitamin D deficiency

in cystic fibrosis. Int J Endocrinol 2010; 2010:218691.

doi:10.1155/2010/218691

Fewtrell MS, Benden C, Williams JE,Chomtho S, Ginty F,

Nigdikar SV,et al. Undercarboxylated osteocalcin and bone

mass in 8 -12 year old children with cystic fibrosis. J Cyst Fibr

; 7:307 -12. doi:10.1016/j.jcf.2007.11.006

Conway SP, Wolfe SP, Brownlee KG, White H, Oldroyd B,

Truscott JG,et al. Vitamin K status among children with cystic

fibrosis and its relationship to bone mineral density and

bone turnover. Pediatrics 2005; 115:1325 -31. doi:10.1542/

peds.2004 -1242

Dodd JD, Barry SC, Barry RB, Cawood TJ, McKenna MJ,

Gallagher CG. Bone mineral density in cystic fibrosis: benefit

of exercise capacity. J Clin Densitom 2008; 11:537 -42.

doi:10.1016/j.jocd.2008.05.095

Arrigo T, De Luca F, Lucanto C, Lombardo M, Rulli I, Salzano

G, et al. Nutritional, glycometabolic and genetic factors affecting

menarcheal age in cystic fibrosis. Diabetes Nutr Metab

; 17:114 -9.

Jin R, Hodges CA, Drumm ML, Palmert MR. The Cystic fibrosis

transmembrane conductance regulator (CFTR) modulates

the timing of puberty in mice. J Med Genet 2006; 43:e29.

doi:10.1136/jmg.2005.032839

Shead EF, Haworth CS, Condliffe AM, McKeon DJ, Scott MA,

Compston JE. Cystic fibrosis transmembrane conductance

regulator (CFTR) is expressed in human bone. Thorax 2007;

:650 -1. doi:10.1136/thx.2006.075887

Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Caminiti

M, et al. Abnormal bone turnover in cystic fibrosis adults.

Osteoporos Int 2002; 13:151 -7. doi:10.1007/s001980200007

Schoenau E, Land C, Stabrey A, Remer T, Kroke A. The

bone mass concept: problems in short stature. Eur J Endocrinol

; 151:S87 -91. doi:10.1530/eje.0.151S087

Fewtrell MS,British Paediatric & Adolescent Bone Group.

Bone densitometry in children assessed by dual X ray absorptiometry:

uses and pitfalls.Arch Dis Child 2003; 88:795 -8.

doi:10.1136/adc.88.9.795

American Academy of Pediatrics. Bone Densitometry in

Children and Adolescents. Pediatrics 2011; 127:189 -94.

doi:10.1542/peds.2010 -2961

National Osteoporosis Society: A practical guide to bone densitometry

in children[Internet]. [citado 2012 Jun 30]. Disponível

em: http://www.nos.org.uk/document.doc?id=851

Nicolaidou P, Stavrinadis I, Loukou I, Papadopoulou A, Georgouli

H, Douros K, et al. The effect of vitamin K supplementation

on biochemical markers of bone formation in children and

adolescents with cystic fibrosis. Eur J Pediatr 2006; 165:540-

-5. doi:10.1007/s00431 -006 -0132 -1

Hind K, Truscott JG, Conway SP. Exercise during childhood

and adolescence: A prophylaxis against cystic fibrosis-

-related low bone mineral density? Exercise for bone health

in children with cystic fibrosis. J Cyst Fibros 2008; 7:270 -6.

doi:10.1016/j.jcf.2008.02.001

Phillipi CA, Remmington T, Steiner RD. Bisphosphonate therapy

for osteogenesis imperfecta. Cochrane Database Syst

Rev 2008; 4:CD005088. doi:10.1002/14651858.CD005088.

pub2.

Conwell LS, Chang AB. Bisphosphonates for osteoporosis

in people with cystic fibrosis. Cochrane Database Syst Rev

; 4:CD002010. doi:10.1002/14651858.CD002010.pub3.

Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE,

Makanji SS, et al. Recombinant human growth hormone in

the treatment of patients with cystic fibrosis. Pediatrics 2010;

:e1211 -26. doi:10.1542/peds.2010 -2007

Published
2016-09-05
How to Cite
Cardoso, K., Pereira, L., & Barreto, C. (2016). CYSTIC FIBROSIS -RELATED BONE DISEASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL, 22(4), 227-233. https://doi.org/10.25753/BirthGrowthMJ.v22.i4.9893
Section
Review Articles